InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-6.7%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Brennan Troyen A, Directeur Médical. Director active across 1 company, notably CVS HEALTH Corp. In total, 14 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €1.7m. Activity tracked since 7 May 2021. The latest transaction was disclosed on 1 April 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
77,960 shares@ US$101.090.0058% mcap20.6% of flowCommon StockSEC:0001127602-22-011639:0
171,944 shares0Common StockSEC:0001127602-22-006283:0
47,937 shares@ US$102.260.0035% mcap12.5% of flowCommon StockSEC:0001127602-22-003406:0
47,937 shares@ US$102.260.0035% mcap31.5% of flowCommon StockSEC:0001127602-22-003406
28,159 shares@ US$58.340.0012% mcap4.1% of flowCommon StockSEC:0001127602-21-028310:0
28,159 shares@ US$58.344.1% of flowCommon StockSEC:0001127602-21-028310
80,802 shares@ US$54.190.0031% mcap10.9% of flowCommon StockSEC:0001127602-21-027755:0
80,802 shares@ US$54.1910.9% of flowCommon StockSEC:0001127602-21-027755
2,625 shares@ US$87.000.0002% mcap0.6% of flowCommon StockSEC:0000947871-21-000985:0
2,625 shares@ US$87.000.6% of flowCommon StockSEC:0000947871-21-000985
65,681 shares@ US$62.219.7% of flowCommon StockSEC:0001127602-21-020199
65,681 shares@ US$62.210.0028% mcap9.7% of flowCommon StockSEC:0001127602-21-020199:0
9,477 shares@ US$84.000.0005% mcap1.9% of flowCommon StockSEC:0001127602-21-016099:0
9,477 shares@ US$84.001.9% of flowCommon StockSEC:0001127602-21-016099
14 of 14 declarations
About Brennan Troyen A
Troyen A. Brennan is the Executive Vice President and Chief Medical Officer at CVS Health Corp. He is responsible for leading medical initiatives and the health strategy of the company. His role is crucial in ensuring the quality of care and innovation in health services.
